Fund Overview of Lic Mf Healthcare Fund Direct - Growth
-
₹91.0 CrAUM
-
₹32.80NAV
-
1.22%Expense Ratio
-
EquityFund Category
Returns of Lic Mf Healthcare Fund Direct - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 3.18% | NA | 6.12% |
| 6 Months | 12.40% | NA | 12.92% |
| 1 Year | 2.28% | 2.28% | 6.04% |
| 2 Years | 61.25% | 26.99% | 24.93% |
| 3 Years | 79.45% | 21.52% | 25.71% |
| 5 Years | 101.96% | 15.09% | 19.91% |
Asset Allocation
equities
97.10%other assets or cash equivalents
2.90%Lic Mf Healthcare Fund Direct - Growth is one Equity mutual fund offered by LIC Mutual Fund. Launched on 28 Feb 2019, the fund aims Long term Capital appreciation. Investment predominantly in equity and equity related instruments of companies engaged in Healthcare & Allied Sectors. It manages assets worth ₹91.0 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹28.26 and ₹33.28. The expense ratio stands at 1.22%. Fund Manager Manager EducationAbout Lic Mf Healthcare Fund Direct - Growth
The portfolio allocation consists of 97.10% in equities, 2.90% in other assets or cash equivalents. Managed by Karan Doshi, it has delivered a return of 2.28% in the last year, a total return since inception of 19.66%.
Key Metrics of Lic Mf Healthcare Fund Direct - Growth
-
Standard Deviation15.56%
-
Sharpe Ratio0.90%
-
Alpha-1.79%
-
Beta0.93%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from LIC Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Lic Mf Healthcare Fund Regular - Growth
|
₹91 | -0.43% | 0.89% | 6.20% | 3.14% | 20.44% |
|
Lic Mf Healthcare Fund Regular-idcw
|
₹91 | -0.43% | 0.89% | 6.20% | 3.14% | 20.44% |
|
Lic Mf Healthcare Fund Direct-idcw
|
₹91 | -0.32% | 1.21% | 6.86% | 4.42% | 21.94% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.10% | ₹9.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.39% | ₹9.10 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.39% | ₹9.10 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.08% | ₹8.59 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.08% | ₹8.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.90% | ₹5.16 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.90% | ₹5.16 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.54% | ₹5.04 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.85% | ₹4.98 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.85% | ₹4.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.40% | ₹4.91 Cr |
| Cipla Ltd | Healthcare | 5.33% | ₹4.85 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.55% | ₹4.73 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.55% | ₹4.73 Cr |
| Cipla Ltd | Healthcare | 5.51% | ₹4.69 Cr |
| Cipla Ltd | Healthcare | 5.51% | ₹4.69 Cr |
| Cipla Ltd | Healthcare | 5.35% | ₹4.69 Cr |
| Cipla Ltd | Healthcare | 5.35% | ₹4.69 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.34% | ₹4.67 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.34% | ₹4.67 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.92% | ₹4.31 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.92% | ₹4.31 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.74% | ₹4.15 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.74% | ₹4.15 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.79% | ₹4.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.79% | ₹4.08 Cr |
| Repo | Unspecified | 4.47% | ₹4.07 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.46% | ₹4.06 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.54% | ₹3.98 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.54% | ₹3.98 Cr |
| Piramal Pharma Ltd | Healthcare | 4.52% | ₹3.96 Cr |
| Piramal Pharma Ltd | Healthcare | 4.52% | ₹3.96 Cr |
| Piramal Pharma Ltd | Healthcare | 4.45% | ₹3.79 Cr |
| Piramal Pharma Ltd | Healthcare | 4.45% | ₹3.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.97% | ₹3.61 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.92% | ₹3.57 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.07% | ₹3.56 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.07% | ₹3.56 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.14% | ₹3.53 Cr |
| Neuland Laboratories Ltd | Healthcare | 4.14% | ₹3.53 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.11% | ₹3.50 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.11% | ₹3.50 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.91% | ₹3.42 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.91% | ₹3.42 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.98% | ₹3.39 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.98% | ₹3.39 Cr |
| Piramal Pharma Ltd | Healthcare | 3.73% | ₹3.39 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.96% | ₹3.37 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.96% | ₹3.37 Cr |
| Abbott India Ltd | Healthcare | 3.66% | ₹3.33 Cr |
| Neuland Laboratories Ltd | Healthcare | 3.52% | ₹3.21 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 3.59% | ₹3.14 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 3.59% | ₹3.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.44% | ₹3.13 Cr |
| Abbott India Ltd | Healthcare | 3.33% | ₹2.84 Cr |
| Abbott India Ltd | Healthcare | 3.33% | ₹2.84 Cr |
| Abbott India Ltd | Healthcare | 3.20% | ₹2.81 Cr |
| Abbott India Ltd | Healthcare | 3.20% | ₹2.81 Cr |
| Gland Pharma Ltd | Healthcare | 3.03% | ₹2.76 Cr |
| Navin Fluorine International Ltd | Materials | 3.11% | ₹2.73 Cr |
| Navin Fluorine International Ltd | Materials | 3.11% | ₹2.73 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.97% | ₹2.70 Cr |
| Artemis Medicare Services Ltd | Healthcare | 3.08% | ₹2.69 Cr |
| Artemis Medicare Services Ltd | Healthcare | 3.08% | ₹2.69 Cr |
| Gland Pharma Ltd | Healthcare | 3.12% | ₹2.66 Cr |
| Gland Pharma Ltd | Healthcare | 3.12% | ₹2.66 Cr |
| Repo | Unspecified | 2.98% | ₹2.61 Cr |
| Repo | Unspecified | 2.98% | ₹2.61 Cr |
| Artemis Medicare Services Ltd | Healthcare | 2.86% | ₹2.60 Cr |
| Gland Pharma Ltd | Healthcare | 2.94% | ₹2.58 Cr |
| Gland Pharma Ltd | Healthcare | 2.94% | ₹2.58 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.81% | ₹2.56 Cr |
| Artemis Medicare Services Ltd | Healthcare | 2.99% | ₹2.55 Cr |
| Artemis Medicare Services Ltd | Healthcare | 2.99% | ₹2.55 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.96% | ₹2.52 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.96% | ₹2.52 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.88% | ₹2.45 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.88% | ₹2.45 Cr |
| Navin Fluorine International Ltd | Materials | 2.66% | ₹2.42 Cr |
| Repo | Unspecified | 2.77% | ₹2.36 Cr |
| Repo | Unspecified | 2.77% | ₹2.36 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.75% | ₹2.34 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.75% | ₹2.34 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.66% | ₹2.33 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.66% | ₹2.33 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.73% | ₹2.32 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.73% | ₹2.32 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.50% | ₹2.28 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.49% | ₹2.27 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.59% | ₹2.27 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.59% | ₹2.27 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.57% | ₹2.25 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.57% | ₹2.25 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.61% | ₹2.22 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.61% | ₹2.22 Cr |
| Navin Fluorine International Ltd | Materials | 2.60% | ₹2.22 Cr |
| Navin Fluorine International Ltd | Materials | 2.60% | ₹2.22 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.42% | ₹2.20 Cr |
| Concord Biotech Ltd. | Healthcare | 2.40% | ₹2.18 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.30% | ₹2.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.45% | ₹2.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.45% | ₹2.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.33% | ₹2.04 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.33% | ₹2.04 Cr |
| Concord Biotech Ltd. | Healthcare | 2.39% | ₹2.03 Cr |
| Concord Biotech Ltd. | Healthcare | 2.39% | ₹2.03 Cr |
| Syngene International Ltd | Healthcare | 2.22% | ₹2.02 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.29% | ₹2.00 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.29% | ₹2.00 Cr |
| Global Health Ltd | Healthcare | 2.31% | ₹1.96 Cr |
| Global Health Ltd | Healthcare | 2.31% | ₹1.96 Cr |
| Global Health Ltd | Healthcare | 2.24% | ₹1.96 Cr |
| Global Health Ltd | Healthcare | 2.24% | ₹1.96 Cr |
| Global Health Ltd | Healthcare | 2.15% | ₹1.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.20% | ₹1.93 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.20% | ₹1.93 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.19% | ₹1.87 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.19% | ₹1.87 Cr |
| Syngene International Ltd | Healthcare | 2.10% | ₹1.84 Cr |
| Syngene International Ltd | Healthcare | 2.10% | ₹1.84 Cr |
| Concord Biotech Ltd. | Healthcare | 2.03% | ₹1.78 Cr |
| Concord Biotech Ltd. | Healthcare | 2.03% | ₹1.78 Cr |
| Syngene International Ltd | Healthcare | 2.07% | ₹1.76 Cr |
| Syngene International Ltd | Healthcare | 2.07% | ₹1.76 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.89% | ₹1.72 Cr |
| Ami Organics Ltd | Healthcare | 1.92% | ₹1.68 Cr |
| Ami Organics Ltd | Healthcare | 1.92% | ₹1.68 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.95% | ₹1.66 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.95% | ₹1.66 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.86% | ₹1.63 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.86% | ₹1.63 Cr |
| Vinati Organics Ltd | Materials | 1.76% | ₹1.60 Cr |
| Vinati Organics Ltd | Materials | 1.78% | ₹1.52 Cr |
| Vinati Organics Ltd | Materials | 1.78% | ₹1.52 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.59% | ₹1.45 Cr |
| Vinati Organics Ltd | Materials | 1.65% | ₹1.44 Cr |
| Vinati Organics Ltd | Materials | 1.65% | ₹1.44 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.65% | ₹1.41 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.65% | ₹1.41 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.48% | ₹1.35 Cr |
| Ami Organics Ltd | Healthcare | 1.42% | ₹1.29 Cr |
| Ami Organics Ltd | Healthcare | 1.50% | ₹1.28 Cr |
| Ami Organics Ltd | Healthcare | 1.50% | ₹1.28 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.38% | ₹1.26 Cr |
| Linde India Ltd | Materials | 1.13% | ₹1.02 Cr |
| Linde India Ltd | Materials | 1.14% | ₹0.97 Cr |
| Linde India Ltd | Materials | 1.14% | ₹0.97 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.05% | ₹0.95 Cr |
| Linde India Ltd | Materials | 1.07% | ₹0.94 Cr |
| Linde India Ltd | Materials | 1.07% | ₹0.94 Cr |
| Net Payables | Unspecified | -0.06% | ₹-0.05 Cr |
| Net Payables | Unspecified | -0.08% | ₹-0.07 Cr |
| Net Payables | Unspecified | -0.08% | ₹-0.07 Cr |
| Net Payables | Unspecified | -0.60% | ₹-0.51 Cr |
| Net Payables | Unspecified | -0.60% | ₹-0.51 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Lic Mf Healthcare Fund Direct - Growth
What is the current AUM of Lic Mf Healthcare Fund Direct - Growth?
As of Thu Jul 31, 2025, Lic Mf Healthcare Fund Direct - Growth manages assets worth ₹91.0 crore
How has Lic Mf Healthcare Fund Direct - Growth performed recently?
- 3 Months: 3.18%
- 6 Months: 12.40%
What is the long-term performance of Lic Mf Healthcare Fund Direct - Growth?
- 3 Years CAGR: 21.52%
- 5 Years CAGR: 15.09%
- Since Inception: 19.66%
What is the portfolio composition of Lic Mf Healthcare Fund Direct - Growth?
Equity: 97.10%, Others: 2.90%.
Who manages Lic Mf Healthcare Fund Direct - Growth?
Lic Mf Healthcare Fund Direct - Growth is managed by Karan Doshi from LIC Mutual Fund.
What is the market-cap allocation of Lic Mf Healthcare Fund Direct - Growth?
Large Cap: 37.33%, Mid Cap: 27.31%, Small Cap: 35.36%.
Which are the top companies Lic Mf Healthcare Fund Direct - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 10.10% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.39% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.39% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.08% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.08% of the fund's portfolio
Which are the major sectors Lic Mf Healthcare Fund Direct - Growth focuses on?
- Healthcare – 457.17% of the fund's portfolio
- Materials – 28.26% of the fund's portfolio
- Unspecified – 14.56% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


